Merck & Co (MRK)
$126.46
0.61 (0.48%)
MRK Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
320.10B
PE Ratio
140.51
EPS
0.9
Volume (Avg. Vol.)
4.67M
Day's Range
$124.91 - $126.60
52-Week Range
$99.14 - $134.63
Dividend & Yield
$2.92 (2.31%)
MRK Stock Predictions, Articles, and Merck & Co News
Dow Jones Today: Data Does It Again
Some solid consumer sentiment and spending reports boosted stocks to close the week, although gains were modest.
3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries
Thursday's 3 big stock charts highlight 3 recent movers that could rally if broad market optimism continues.
Dow Jones Today: Struggling at the Highs
Some of today's malaise can be attributed to Alphabet (NASDAQ:GOOGL,GOOG), which declined following a disappointing earnings report issued yesterday after the market closed. The internet search giant reported earnings of $10.12 a share on revenue of $40.50 billion while analysts expected earnings of $12.42 on revenue of $40.32 billion.
Stock Market Today: Earnings, Fed Drive New Highs
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
Dow Jones Today: Fed Obliges, Stocks Don’t
A divided Federal Reserve is a new issue for investors to consider. Read more about what happened in the Dow Jones today.
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
A Pairs Prescription for CVS Stock and Merck
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
4 Drug Stocks Getting Smashed
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
Dow Jones Today: Averting Catastrophe, but Nothing to Brag About
As has been noted in this space, market participants are pricing in the following Fed facts: no interest rate cut this month and no cuts totaling 50 basis points this year. Hope burns eternal for a rate reduction of 25 basis points, but Powell's two-day testimony and the June meeting minutes could indicate otherwise.
Two Healthcare Stocks in the XLV Fund Stand Out
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
